RIT Hosts News Conference on Economic Impact of Biopharmaceutical Sector Nov. 13
Speakers will include Assemblyman Joseph Morelle and industry representatives
Pharmaceutical research and biotechnology companies remain an economic force throughout New York, and a new study shows the industry has strong potential for continued long-term growth.
RIT’s Center for Bioscience Education and Technology will host a press conference at 11 a.m. Friday highlighting findings from the “Economic Impact of the Biopharmaceutical Sector on New York State.” The conference will be held in the lobby of the CBET building.
Speakers will include Ed Belkin, vice president of the Pharmaceutical Research and Manufacturing Association of America; Joseph Morelle, New York state assemblyman; Gary Skuse, interim head of the School of Biological and Medical Sciences at RIT; Nathan Tinker, executive director of the New York Biotechnology Association; and Nancy Bergsteinsson, consultant from Archstone Co., which prepared the report.
An analysis of the impact of the biopharmaceutical sector on the economy of New York, using data primarily from 2006, includes the following highlights:
• Total employment: The biopharmaceutical industry directly employs 55,546 people and is responsible for a total of 130,464 jobs;
• Total output: The biopharmaceutical industry generated $29.1 billion in total output, of which $16.0 billion was generated from direct employment. New York state is responsible for 6.8 percent of all direct biopharmaceutical output nationally;
• Tax revenue generated: The industry was responsible for $845.6 million in federal and social security taxes and $121.0 million in state taxes paid due to direct employment;
• Clinical trials: In 2008, New York was second in the nation with 5,053 clinical trial sites in the state; and
• Top regions: The regions that have the best ‘clustering’ effect are Long Island, Rochester and Westchester.
The Center for Bioscience Education and Technology at RIT is the Rochester region’s hub for customized workforce training, education and professional-development services in the biosciences. As a complement to RIT’s traditional academic degree programs, CBET serves a broad and diverse population of bioscience workers and others whose professions intersect regularly with the bioscience and health-related fields.
March 15, 2019
Data science community to gather at RIT for regional DataFest hackathon March 29-31
Teams of three to five students will have 48 hours to mine a complex data set pertaining to a real-world problem. Teams will test their statistical analytic and data science skills to find the best solution.
March 13, 2019
RIT Associate Professor Suzanne O’Handley nationally recognized for mentorship
RIT Associate Professor Suzanne O’Handley has been selected by the Council on Undergraduate Research and the Goldwater Scholarship Foundation as the 2019 CUR-Goldwater Scholars Faculty Mentor Awardee. O’Handley, a faculty member in RIT’s School of Chemistry and Materials Science, was chosen from 10 finalists for her considerable achievements as a dynamic scholar, teacher and mentor.
March 8, 2019
RIT Venture Creations technology business incubator launches four new companies
From eye tracking to thermal cooling to all things mushrooms, RIT’s Venture Creations technology business incubator celebrated the launch of four new startups.
March 6, 2019
Student Spotlight: Showing the artistic side of science
Meet Deirdre Cannon, a first-year biotechnology and molecular bioscience student who loves drawing.